4//SEC Filing
Eisner Mark 4
Accession 0001209191-23-012425
CIK 0000921299other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:38 PM ET
Size
7.2 KB
Accession
0001209191-23-012425
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Eisner Mark
Incoming Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-21+55,000→ 55,000 totalExercise: $22.60Exp: 2033-02-20→ Common Stock (55,000 underlying) - Award
Common Stock
2023-02-21+32,500→ 173,683 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2024, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years.
- [F2]Twenty-five percent of the shares subject to the option will vest on March 1, 2024, and the remainder of the options will vest in equal amounts quarterly thereafter for the following three years.
Documents
Issuer
FIBROGEN INC
CIK 0000921299
Entity typeother
Related Parties
1- filerCIK 0001834161
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:38 PM ET
- Size
- 7.2 KB